학술논문
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
Document Type
Article
Author
Source
In: Scientific Reports . (Scientific Reports, December 2023, 13(1))
Subject
Language
English
ISSN
20452322